GEN Exclusives

More »

GEN News Highlights

More »
Feb 23, 2010

DeveloGen and Istituto Raffaele Win $500K JDRF Grant for R&D in Beta-Cell Regeneration

  • DeveloGen garnered a $500,000 grant from the Juvenile Diabetes Research Foundation to fund a project focused on developing new approaches to protecting insulin-producing beta cells. The work will be carried out in partnership with the Istituto San Raffaele in Milan.

    DeveloGen is focused on the discovery and development of novel therapeutics for the treatment of metabolic and endocrine disorders, in particular diabetes. The firm’s aim is to identify and exploit mechanisms involved in the dynamic regulation of beta-cell mass to develop drugs that stimulate the regeneration or protection of beta cells in diabetic patients.

    In 2006, DeveloGen received its first grant from JDRF to support the development of new approaches to beta-cell regeneration. The firm claims ongoing research has identified novel secreted factors from early embryonic stages of pancreas development that demonstrate the ability to stimulate beta-cell differentiation and/or proliferation.   


Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »